Unity Biotechnology, Inc.
Open: 11:44 AM
UBX Stock Price Graph
UBX Stock Price Today
Unity Biotechnology, Inc. (UBX) stock declined over -4.66% intraday to trade at $1.84 a share on NASDAQ. The stock opened with a loss of -9.33% at $1.75 and touched an intraday high of $1.87, falling -4.66% against the last close of $1.93. The Unity Biotechnology, Inc. in stock market went to a low of $1.74 during the session.
UBX Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
UBX Stock Price History Chart
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
Frequently Asked Questions
What is the current Unity Biotechnology, Inc. (UBX) stock price?
Unity Biotechnology, Inc. (NASDAQ: UBX) stock price is $1.84 in the last trading session. During the trading session, UBX stock reached the peak price of $1.87 while $1.74 was the lowest point it dropped to. The percentage change in UBX stock occurred in the recent session was -4.66% while the dollar amount for the price change in UBX stock was -$0.09.
UBX's industry and sector of operation?
The NASDAQ listed UBX is part of Biotechnology industry that operates in the broader Healthcare sector. Unity Biotechnology, Inc. , a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.
Who are the executives of UBX?
Mr. Alexander Azoy
Vice President of Fin., Chief Accounting Officer, Controller & Principal Accounting Officer
Dr. Anirvan Ghosh Ph.D.
Chief Executive Officer & Director
Ms. Lynne Marie Sullivan
Chief Financial Officer & Head of Corporation Devel.
Mr. Alexander Azoy
VP of Fin., Chief Accounting Officer, Controller & Principal Accounting Officer
How UBX did perform over past 52-week?
UBX's closing price is 0.56% higher than its 52-week low of $1.461 where as its distance from 52-week high of $5.72 is -0.88%.
How many employees does UBX have?
Number of UBX employees currently stands at N/A. UBX operates from 285 East Grand Avenue, South San Francisco, CA 94080, US.
Link for UBX official website?
Official Website of UBX is: https://unitybiotechnology.com
How do I contact UBX?
How many shares of UBX are traded daily?
UBX stock volume for the day was 48862.00 shares. The average number of UBX shares traded daily for last 3 months was 66.12 Thousands.
What is the market cap of UBX currently?
The market value of UBX currently stands at $26.75 Million with its latest stock price at $1.84 and N/A of its shares outstanding.